Molecular and phenotypic traits of in-vitro-selected mutants of Bifidobacterium resistant to rifaximin

Int J Antimicrob Agents. 2008 Jun;31(6):555-60. doi: 10.1016/j.ijantimicag.2008.02.002. Epub 2008 May 6.

Abstract

Nucleotide mutations inside a core region of the rpoB gene, encoding the beta subunit of RNA polymerase, were found in rifaximin-resistant mutants of Bifidobacterium. Five different missense mutations of codons 513, 516, 522 and 529 were identified. Further aspects of rifaximin resistance were investigated, using Bifidobacterium infantis BI07 as a model strain. Partial resistance of RNA polymerase of a BI07 mutant at a rifaximin concentration >10 microg/mL was observed by cell-free transcription assay. Mass spectrometry detection of rifaximin in the cellular pellet of the BI07 resistant mutant, as well as changes in biosynthesis of saturated and cyclopropane fatty acids during growth, suggested a reduction in membrane permeability for the antibiotic moiety.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Bifidobacterium / drug effects*
  • Cell Membrane / chemistry
  • Cell Membrane Permeability / drug effects
  • Cell Membrane Permeability / genetics
  • Chromatography, Gas
  • DNA-Directed RNA Polymerases / metabolism
  • Drug Resistance, Bacterial / genetics*
  • Fatty Acids / chemistry
  • Fatty Acids / metabolism
  • Genes, Bacterial
  • Mass Spectrometry
  • Mutation / genetics
  • Phenotype
  • Rifamycins / pharmacology*
  • Rifaximin
  • Transcription, Genetic

Substances

  • Anti-Bacterial Agents
  • Fatty Acids
  • Rifamycins
  • DNA-Directed RNA Polymerases
  • Rifaximin